Alaunos Therapeutics, Inc.

Alaunos Therapeutics, Inc.verified

TCRT

Price:

$2.26

Market Cap:

$5.52M

Alaunos Therapeutics, Inc. is an oncology company in the clinical trial phase, specializing in the creation of adoptive T-cell receptor (TCR) engineered therapies. Their pipeline includes a TCR Library, currently undergoing Phase I/II clinical trials, which comprises ten T-cell receptors designed to target mutated KRAS, TP53, and EGFR in various cancers such as non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. Additionally, they are advancing hunTR, a platform focused on human neoantigen T-cell receptors, and mbIL-15, intended for solid tumor treatment. The company maintains strategic collaborations, including a licensing agreement with PGEN Therapeuti...[Read more]

Industry

Biotechnology

IPO Date

2005-08-24

Stock Exchange

NASDAQ

Ticker

TCRT

The Enterprise Value as of June 2026 (TTM) for Alaunos Therapeutics, Inc. (TCRT) is 5.17M

According to Alaunos Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 5.17M. This represents a change of 10.48% compared to the average of 4.68M of the last 4 quarters.

Alaunos Therapeutics, Inc. (TCRT) Historical Enterprise Value (quarterly & annually)

How has TCRT Enterprise Value performed in the past?

The mean historical Enterprise Value of Alaunos Therapeutics, Inc. over the last ten years is 278.00M. The current 5.17M Enterprise Value has changed 85.80% with respect to the historical average. Over the past ten years (40 quarters), TCRT's Enterprise Value was at its highest in in the June 2019 quarter at 843.82M. The Enterprise Value was at its lowest in in the December 2024 quarter at 1.97M.

Quarterly (TTM)
Annual

Average

278.00M

Median

197.18M

Minimum

1.97M

Maximum

715.34M

Alaunos Therapeutics, Inc. (TCRT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Alaunos Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 246.19%

Maximum Annual Enterprise Value = 715.34M

Minimum Annual Increase = -91.06%

Minimum Annual Enterprise Value = 1.97M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20254.91M149.48%
20241.97M-81.97%
202310.91M-91.06%
2022121.96M-35.04%
2021187.73M-55.09%
2020418.03M-41.56%
2019715.34M246.19%
2018206.63M-58.34%
2017495.98M-19.55%
2016616.54M-31.61%

Alaunos Therapeutics, Inc. (TCRT) Average Enterprise Value

How has TCRT Enterprise Value performed in the past?

The current Enterprise Value of Alaunos Therapeutics, Inc. (TCRT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

5.93M

5-year avg

65.50M

10-year avg

278.00M

Alaunos Therapeutics, Inc. (TCRT) Enterprise Value vs. Peers

How is TCRT’s Enterprise Value compared to its peers?

Alaunos Therapeutics, Inc.’s Enterprise Value is less than Radiopharm Theranostics Limited (12.78M), less than Cyclerion Therapeutics, Inc. (11.25M), greater than Pasithea Therapeutics Corp. (-46001320.00), greater than VYNE Therapeutics Inc. (-13823812.00), less than Quoin Pharmaceuticals, Ltd. (5.31M), greater than Addex Therapeutics Ltd (4.62M), less than Polyrizon Ltd. (11.16M), greater than AIM ImmunoTech Inc. (139.50K), less than XTL Biopharmaceuticals Ltd. (5.58M), less than Impact BioMedical Inc. (7.29M),

Build a custom stock screener for Alaunos Therapeutics, Inc. (TCRT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Alaunos Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Alaunos Therapeutics, Inc. (TCRT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Alaunos Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Alaunos Therapeutics, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Alaunos Therapeutics, Inc. (TCRT)?

What is the 3-year average Enterprise Value for Alaunos Therapeutics, Inc. (TCRT)?

What is the 5-year average Enterprise Value for Alaunos Therapeutics, Inc. (TCRT)?

How does the current Enterprise Value for Alaunos Therapeutics, Inc. (TCRT) compare to its historical average?